Epilepsy

The Epilepsy pipeline: 73 tracked drugs, 47 approved for this indication.

47 approved / phase 411 Phase 32 Phase 2/36 Phase 24 Phase 1/23 Phase 1

Compare the share prices of listed companies in Epilepsy →

Total attributable cost

$15.6B

$4,580/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities (active epilepsy) · US

The Epilepsy pipeline

Key trial results for every approved and late-stage drug: Epilepsy results by drug.

← all assets